Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-04

Clinical Trial Update: CBT4CBT for Office Based Buprenorphine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CBT4CBT adjunctive therapy in office-based buprenorphine treatment for opioid-use disorder has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBT4CBT
  • buprenorphine (buprenorphine)

Snippet

Sponsor: CBT4CBT, LLC | Conditions: Opioid-use Disorder | Phase 1, Phase 2 | Status: COMPLETED